Dye & Durham Reports Preliminary Unaudited Fiscal 2025 and Q1 Fiscal 2026 Results and Provides Updated Business Outlook

CNW/ - Dye & Durham Limited (the "Company" or "Dye & Durham") (TSX: DND) today announced preliminary unaudited results for ...

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms ...
Cantech Letter

MediPharm Labs Files Proxy Materials, Issues Chair’s Letter to Shareholders

MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ...

Why FMC Corporation Is Not Worth The Risk Even After A ~50% Cut

FMC Corporation faces severe challenges from high leverage, macro headwinds, and the expiration of a key product patent. Read ...
AccessWDUN

Assurant Reports Strong Third Quarter 2025 Financial Results and Increases Full Year Outlook

Assurant Reports Strong Third Quarter 2025 Financial Results and Increases Full Year OutlookThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Nov 4, 2025– Assurant, Inc. (NYSE: AIZ): (Unaudited) ...